INTrOduCTION
Amyloid β (Aβ) accumulation, mitochondrial dysfunction and oxidative stress are early steps in the pathogenesis of Alzheimer's disease (AD) (Holscher, 1998; Yatin et al., 1999; Butterfield, 2002; Perry et al., 2002; Selkoe, 2001; 2006; Butterfield & BoydKimball, 2004; Pratico & Sung, 2004; Hauptmann et al., 2006) . Aβ is derived from the amyloid precursor protein (APP) through an initial β-secretase cleavage followed by an intramembraneous cut by γ-seceretase (Buchet & Pikuła, 2000; Selkoe, 2001; Haass, 2004) . Certain mutations of the APP gene enhance intracellular Aβ production and lead to intracellular and extracellular Aβ accumulation in transfected cell lines or transgenic animals (Citron et al., 1997; Cai et al., 1993) . In our previous study we showed that the Swedish double mutation in the human APP gene (K670M/N671L) resulted in a significantly higher Aβ production in transfected PC12 cells (APPsw) compared with human wild type APP-transfected PC12 cells (APPwt) (Eckert et al., 2001; Keil et al., 2004) . Further studies have shown that the APPsw mutation induces oxidative stress, enhances nitric oxide (NO) level, induces mitochondrial dysfunction, and finally leads to an enhanced vulnerability to apoptotic cell death through the activation of c-Jun N-terminal kinase, caspase 3 and 9, release of cytochrome c, and ATP depletion (Marques et al., 2003; Keil, et al., 2004) .
Previous studies from our and others groups indicate that NO is involved in PLA 2 activation through phosphorylation by PKC, ERK1/2 protein kinases as well as cGMP-dependent protein kinase (PKG) (Chalimoniuk et al., 2006) and leads to enhanced arachidonic acid (AA) release. Activation of PLA 2 mediates AA release from the sn-2 position of phospholipids. Several isoforms of PLA 2 have been identified in neurons, such as cytosolic calciumdependent PLA 2 (cPLA 2 ), secretory (sPLA 2 ) and Ca 2+ -independent (iPLA 2 ) (Murakami et al., 1997; Farooqui et al., 1997; Mollay et al., 1998; Sun et al., 2004) . cPLA 2 is activated by increase in [Ca 2+ ] i (range 100-500 nM) that binds to NH-domain and induces translocation of cPLA 2 to membrane. Interestingly, enhanced cPLA 2 expression has been described in the brain of AD patients (Stephenson et al., 1996) .
Excessive NO-and AA release-mediated neurotoxicity seems to be involved in brain aging, amyloid β toxicity and in the pathomechanism of AD (Chalimoniuk & Strosznajder, 1998; Ross et al., 1998; Keil et al., 2004) . Thus, enhanced NO generation may link mitochondrial dysfunction and oxidative stress with the arachidonic acid cascade, but the detailed mechanisms need to be clarified. Accordingly, we investigated the possible relationship between enhanced Aβ secretion, NOS activity, cPLA 2 level, and AA release using control, APPwt, and APPsw PC12 cells.
MATerIAL ANd MeThOdS
PC12 cell culture. PC12 (pheochromocytoma) cells were transfected with DNA constructs harboring human mutant APP gene (APPsw, K670M/ N671L) or APPwt gene according to Keil et al. (2004) . Transfected APPwt PC12 cells, PC12 cells bearing the Swedish double mutation in the amyloid precursor protein gene (APPsw), and control PC12 cells (transfected with empty vector) were cultured in 75 cm 2 flasks in DMEM supplemented with 10%-heat-inactivated fetal bovine serum (FBS), 5% heat-inactivated horse serum (HS), 0.5% penicillin/streptomycin (50 U/ml), 400 µg/ml G418 and 2 mM glutamine. Cells were maintained at 37 o C in a humidified incubator containing 5% CO 2 . Cells were subcultured about once a week. For experiment, confluent cells were subcultured into polyethylenimine-coated 35 mm 2 dishes or 24-well plates. Cells were used for experiments at 75-90% confluence or one day after being plated in the 24-well plate. Prior to treatment, cells were replenished with 2% FBS medium or with serum-free medium.
determination of Aβ 1-40 . Cells were plated at equal density in 6-well plates. After reaching confluence, 2 ml of conditioned media was collected after 24 h of culture. Media were centrifuged to remove cell fragments, and aliquots were then used to determine the Aβ 1-40 level. For determination of secreted Aβ 1-40 , a specific sandwich enzyme-linked immunosorbent assay (ELISA) employing monoclonal antibodies was used. The ELISA was performed according to the instructions given in the Aβ-ELISA kit by Biosources (San Diego, CA, USA). The assay principle is that of a standard sandwich ELISA, which utilizes a site-specific rabbit anti-human Aβ 1-16 capture, a cleavage site-specific rabbit anti-human Aβ 1-40 terminal detection antibody, and anti-rabbit IgG peroxidase-cojugated secondary antibody.
PC12 cell treatment. Cells were treated with inhibitors of: cPLA 2 (arachidonyl trifluoromethyl ketone, AACOCF 3 , 1 µM), γ-secretase (N-[N-(3,5-trifluorophenacetyl)-l-alanyl]-S-phenyglycine t-butyl ester, DAPT, 1 µM), Ca 2+ -dependent NOS (N-nitrol-arginine, NNLA, 10 µM) or neuronal NOS ((4S)-N-(4-amino-5[aminoethyl]aminopentyl)-N'-nitroguanidine, NANNG, 1 µM) for 30 min at 37 o C. Moreover, the cells were treated with 1 mM sodium nitroprusside (SNP) in the absence or presence of PLA 2 inhibitor (AACOCF 3 , 1 µM) for 30 min as described in legend to figures.
Determination of nitric oxide synthase (NOS) activity. NOS activity was determined by measuring
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Amyloid β enhances cytosolic phospholipase A2 the conversion of [ 3 H]l-arginine to [ 3 H]l-citrulline as described by Chalimoniuk et al. (2006) . Briefly, cells were washed with warm PBS and incubated in culture dishes for 20 min at 37°C with 3 µCi/mL [ 3 H]l-arginine (Amersham Biosciences, Piscataway, NJ, USA) in Hank's buffer. Following this incubation period, cells were washed in ice cold PBS and lysed with 0.3 M HClO 4 . The lysate was neutralized with 1 M Na 2 CO 3 and centrifuged at 3000 × g for 10 min. Then, 400 µl of supernatant was applied to a Dowex AG 50WX (Na + ) column. The [ 3 H]l-citrulline formed was eluted with 1 ml of water and 500 µl of the elution was mixed with 5 ml of scintillation cocktail. The radioactivity was quantified using an LKB 1409 Wallac scintillation counter. To determine the cellular uptake of [ 3 H]l-arginine from each dish, radioactivity from a 50 µl aliquot of supernatant was also quantified. NOS activity was expressed as percentage of control (NOS activity in control PC12 cells).
Determination of cellular cGMP level. Cyclic GMP was determined using a commercially available ELISA kit (Amersham Biosciences, Piscataway, NJ, USA) according to the procedure supplied by the manufacturer. This method allows measuring cGMP in the range of 2-512 pmol/well, and it is based on a competition between cGMP present in the sample with peroxidase-labeled cGMP for binding to specific anti-cGMP antibody. Briefly, medium was collected into new tubes and cells were washed with PBS. Then, the medium and cell lysate samples were acetylated. Acetylated samples were incubated with an anti-cGMP antibody for 2 h at 4°C and then with cGMP conjugated to horseradish peroxidase for 60 min at 4°C. 3,3'5'5'-Tetramethylbenzidine was used as a substrate for horseradish peroxidase. To quantify cellular cGMP levels (pmol/10 5 cells) a standard curve was generated using a standard solution of cGMP.
Determination of free radicals using 2',7-dichlorofluorescein (dCF). The dichlorofluorescein (DCF) fluorescence assay detects the level of hydrogen peroxide and other free radicals in cells. Free radicals were determined based on reactive oxygen species-mediated conversion of 2',7-dichlorofluorescein diacetate into fluorescent DCF (Royall & Ischiropoulos, 1993; Adamczyk et al., 2006) . PC12 cells were loaded with 10 µM 2',7-dichlorofluorescein diacetate (H 2 DCFDA) in DMSO by incubating for 50 min at 37 o C. DMSO was used at a final concentration of 0.05% and at this concentration had no effect on free radicals levels. Cells were washed three times in PBS buffer. Fluorescence of DCF was measured using a Perkin Elmer LS 50B spectrofluorometer with excitation and emission wavelengths at 488 and 525 nm, respectively. DCF fluorescence is reported as intensity per mg protein.
Mitochondrial oxidative stress (dihydrorhodamine (dhr) fluorescence). DHR detects the level of reactive oxygen species in mitochondria (Hempel et al., 1999) . DHR is the non-fluorescent reduced form of rhodamine 123. Due to its lipophilicity it can easily diffuse through cell membranes. Inside the cell, it is oxidized by various ROS to the positively charged fluorescent rhodamine 123 which is incorporated into the mitochondria. DHR mainly detects hydrogen peroxide, especially in the presence of cytochrome c oxidase in mitochondria and can thus be used as a marker for mitochondrial ROS production. PC12 cells were incubated with 10 µM dihydrorhodamine in DMEM for 15 min at 37 o C. After incubation cells were washed twice with HBSS. Fluorescence of dihydrorhodamine (DHR) was measured using a fluorescence reader (Victor multilabel counter) with excitation and emission wavelengths at 490 and 535 nm, respectively.
Detection of superoxide anions with dihydroethidium (DHE). Superoxide anions can be detected by oxidation of DHE (Rothe & Valet, 1990) . Upon oxidation, DHE forms ethidium that intercalates into DNA double strands in the cell. When stacked between the bases, the π-electrons of the dye interact with the π-electrons of the DNA bases, resulting in altered fluorescence properties. PC12 cells were incubated with 40 µM dihydroethidium in Hank's balanced salt solution (HBSS) for 60 min at 37 o C. After incubation cells were washed twice with HBSS. Fluorescence of ethidium was measured using a fluorescence reader (Victor multilabel counter) with excitation and emission wavelengths at 535 and 590 nm, respectively.
Cu,Zn-SOD activity. Cu,Zn-SOD activity was measured with the superoxide dismutase assay kit (Calbiochem by VWR International GmbH, Darmstadt, Germany). To remove interfering substances and rule out Mn-SOD activity, the Cu,Zn-SOD activity was assayed after extraction with chloroform and ethanol according to the supplier's manual. SOD activity was calculated based on the Vs/Vc ratio of the autooxidation rates of the chromophore BXT-01050 measured at 37°C in the presence (Vs) and absence (Vc) of sample. The chromophore was measured in a Genesys 5 photometer (Spectronic Instruments, Rochester, USA) at 525 nm. One Cu,Zn-SOD activity unit is defined as the activity that doubles the autooxidation background (Vs/Vc = 2).
Glutathione peroxidase (GPx) activity. GPx (cytosolic GPx) activity was measured using the cellular glutathione peroxidase assay kit (Calbiochem by VWR International GmbH, Darmstadt, Germany) and tert-butylhydroperoxide as substrate. This reaction is based on the enzymatic reduction of hydroperoxide by GPx with consumption of reduced glutathione GSH which is restored from oxidized 614 2007 M. Chalimoniuk and others glutathione GSSG in a coupled enzymatic reaction by glutathione reductase (GR). This enzyme reduces GSSG to GSH with consumption of NADPH as reducing equivalents. The decrease in absorbance at 340 nm due to NADPH consumption was measured in a Victor multiplate reader using a 355 nm filter with 40 nm bandpass. One unit of GPx was defined as the activity that converts 2 µmol of reduced glutathione per minute at 25°C.
Glutathione reductase (Gr) activity. The GR activity was determined using the glutathione reductase assay kit (Calbiochem by VWR International GmbH, Darmstadt, Germany). The enzymatic activity was assayed photometrically by measuring NADPH consumption during the enzymatic reaction. In the presence of GSSG and NADPH, GR reduces GSSG and oxidizes NADPH to yield NADP, resulting in a decrease of absorbance at 340 nm, which was measured in a Victor plate reader. One unit of GR is defined as the activity that reduces 1 µmol of GSSG (corresponding to 1 µmol of NADPH) per minute at 25°C.
Gel electrophoresis and western blotting for detection of cPLA 2 and phosphorylated cPLA 2 . Cell lysate (40 µg protein) was mixed with an equal volume of sample buffer SB (62.5 mM Tris/ HCl, 2% SDS, 100 mM DTT, 20% glycerol and 0.2% bromophenol blue, pH 6.8, (Laemmli, 1970) ). The samples were heated for 5 min at 95°C. The proteins were analyzed by electrophoresis on 10% polyacrylamide gel. Then, proteins were electrophoretically transferred from the polyacrylamide gel to nitrocellulose membranes (Bio-Rad) at 4 mA/cm 2 of gel for 2 h. The membrane was blocked in 5% milk powder in Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBS-T) for 1 h at room temp. Then the membrane was incubated with rabbit polyclonal anticPLA 2 antibody or anti-p-cPLA 2 antibody (Cell Signaling, Beverly, MA, USA) (diluted 1 : 200 or 1 : 1000 in TBS-T containing 2% (w/v) non-fat milk, respectively) overnight at 4 o C. The cPLA 2 or p-cPLA 2 antibody complex was identified with anti-rabbit IgG antibody conjugated with horseradish peroxidase (ARHRP, diluted 1 : 5000 in TBS-T containing 5% (w/ v) non-fat milk) by incubation for 1 h at room temp. The anti-cPLA 2 -ARHRP and anti-p-cPLA 2 -ARHRP were visualized with the ECL kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA) and Hyperfilm-Kodak (Sigma, St. Louis, MO, USA). The optical densities of the cPLA 2 and phospho-cPLA 2 bands on the immunoblot were quantified using a NucleoVision apparatus and GelExpert 4.0 software from NucleoTech (San Manteo, CA, USA).
Assessment of AA release from PC12 cells. AA release was quantified essentially as described previously (Samanta et al., 1998; Xu et al., 2002) with some minor modifications. Briefly, 0.1 µCi of [ 3 H]AA (NEN, specific radioactivity 55 Ci/mol) was suspended in DMEM medium containing 0.5% BSA and added directly to PC12, APPsw or APPwt cells cultured in a 35 mm dish. After incubation for 4 h at 37 o C, unincorporated labeled AA was removed by three successive washings with buffer A containing 145 mM NaCl, 5.5 mM KCl, 1.1 mM MgCl 2 , 1.1 mM CaC1 2 , 5.5 mM glucose, 20 mM Hepes, pH 7.4, and BSA (0.5 mg/ml). Cells were preincubated in buffer A for 30 min at room temp. Then the cells were treated with inhibitors of cPLA 2 (AACOCF 3 , 1 µM), γ-secretase (DAPT, 1 µM), calcium-dependent NOS (NNLA, 10 µM) or with a specific neuronal NOS inhibitor (NANNG, 1 µM) for 30 min at 37 o C. In some experiments, cells were subsequently incubated with sodium nitroprusside (SNP, 1 mM) without or with 1 µM AACOCF 3 for 30 min at 37 o C. After incubation, cell media were transferred to scintillation tubes and radioactivity in the supernatant was determined using an LKB 1409 Wallac scintillation counter.
Cytosolic calcium measurements. Cells were plated onto polylysine-coated glass cover slips or multi-well plates one day before experiments. Measurement of the intracellular Ca 2+ concentration ([Ca 2+ ] i ) was carried out using the fluorescent indicator fura-2 in combination with a monochromatorbased imaging system (T.I.L.L. Photonics, Gräfelfing, Germany) attached to an inverted microscope (Axiovert 100, Zeiss, Jena, Germany). PC12 cells were loaded with 5 µM fura-2-AM (Molecular Probes, Leiden, The Netherlands) supplemented with 0.05% Pluronic F127 for 45 min at 37°C in a standard solution containing 138 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 5.5 mM glucose and 10 mM Hepes (adjusted to pH 7.4 with NaOH). The cells were washed once with HBSS and, to ensure complete AM ester hydrolysis, kept for 30 min at room temp. in the dark. For [Ca 2+ ] i measurements, fluorescence was excited at 340 and 380 nm. After correction for the individual background fluorescence, the fluorescence ratio F340/F380 was calculated.
Mitochondrial calcium measurements. For qualitative estimation of mitochondrial calcium [Ca 2+ ] m , the cells were loaded with 3 µM dihydrorhod-2/AM (rhod-2/AM reduced with NaBH 4 ) in the presence of 0.02% Pluronic® in Hank's balanced salt solution (HBSS, pH 7.4) for 45 min at 37°C. The cells were washed once with HBSS and, to ensure complete AM ester hydrolysis, were kept for 20-30 min at room temp. in the dark. After a second wash step, the fluorescence was determined with a fluorescence reader (Victor ® multilabel counter) at 550/574 nm.
Statistic analysis. The results were expressed as mean values ± S.E.M. Differences between means were analyzed using one-way or two-way (type of cells and treatment) ANOVA followed by the New-
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man-Keuls test when appropriate. P < 0.05 was considered statistically significant. The statistical analyses were performed by using Statistic version 4.0.
reSuLTS
Control PC12 cells, PC12 cells bearing the Swedish double mutation of human APP gene (APPsw) or those transfected with human APP (APPwt) have been described previously (Marques et al., 2003; Keil et al., 2004) . The cells expressing human wild-type APP and mutant APP showed 2.8-and 4.8-fold higher Aβ production comparing to PC12 cells transfected with empty vector (Table 1) . Moreover, the data of Eckert et al. (2001) demonstrated similar properties of non-transfected PC12 cells and those transfected with empty vector.
We observed an increase of NOS activity and cGMP level in APPsw and APPwt PC12 cells compared to control PC12 cells (Fig. 1A, B and C) . The NOS activity in APPsw PC12 cells was 1.4-fold higher than in control PC12 cells (Fig. 1A) . The activity of NOS increased 1.3-fold in APPwt PC12 cells compared to control cells, but was significantly lower than in APPsw PC12 cells (Fig. 1A) . The increased NOS activity was accompanied by enhanced intracellular and extracellular cGMP levels in APPsw and APPwt cells (Fig. 1B and C) . The highest intracellular and extracellular cGMP levels were observed in APPsw PC12 cells (Fig. 1B and C) . Thus, elevated Aβ generation increased NOS activity and cGMP concentration.
In agreement with our previous findings that cPLA 2 activity and AA release can be enhanced by in vitro added NO donors like sodium nitroprusside (Fig. 2 ). An inhibitor of cPLA 2 , AACOCF 3 , decreased the AA release significantly, by about 30%, 
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15% and 15% in APPsw, APPwt and control PC12 cells, respectively (Fig. 2) . N-Nitro-l-arginine (NNLA), an inhibitor of Ca 2+ -dependent NOS, and the specific neuronal NOS inhibitor NANNG also significantly lowered the AA release in all investigated cells (Fig. 2) .
Enhanced AA release was paralleled by higher immunoreactivity of cPLA 2 protein in APPsw and APPwt PC12 cells compared with control PC12 cells. APPsw PC12 cells showed a 1.50-and 2.25-fold increased immunoreactivity of cPLA 2 compared to APPwt and control PC12 cells, respectively (Fig. 3) . The activity of PLA 2 is regulated by phosphorylation. For determination of phosphorylated cPLA 2 protein level we used Ser 505 phospho-cPLA 2 antibody. Phosphorylated cPLA 2 protein levels were about 1.7-and 1.47-fold higher in APPsw and APPwt PC12 cells versus control PC12 cells, respectively (Fig. 4) .
After incubation with the NO donor, SNP (1 mM), [ 3 H]AA release was significantly increased in all investigated cells (APPwt, APPsw, control PC12 cells) (Fig. 5) . However, the highest SNP-induced the AA release was noted in control PC12 cells, where SNP increased AA release about 1.3-fold relative to non-treated PC12 cells. In APPsw PC12 cells and APPwt cells, AA release after SNP treatment was significantly increased but to a lesser extend than in control PC12 cells probably due to the already enhanced AA liberation by elevated endogenous NO concentration (Fig. 5) . The basal but also the SNP-elevated AA release was significantly inhibited by the cPLA 2 inhibitor AACOCF 3 (Fig. 5) .
Similar to its effect on cPLA 2 activity, SNP also enhanced cPLA 2 protein level and again this effect was higher in control PC12 than in APPwt or APPsw PC12 cells (Fig. 6) . We have previously shown that the γ-secretase inhibitor DAPT reduced efficiently Aβ overproduction and mitochondrial dysfunction by normalizing NO and ATP levels as well as mitochondrial membrane potential in APPsw PC12 cells (Keil et al., 2004) . In agreement with those data, DAPT reduced the enhanced AA release in APPsw PC12 cells (Fig. 7) , confirming the relationship between enhanced Aβ levels on the one hand and elevated NO and cPLA 2 levels on the other.
As cPLA 2 activity is regulated by the free intracellular Ca 2+ concentration [Ca 2+ ] i , we investigated possible changes of [Ca 2+ ] i in control and transfected PC12 cells. The basal cytosolic and mitochondrial Ca 2+ levels are the same in all investigated cell lines ( Fig. 8 A and C) . Under these basal conditions cPLA 2 is mainly activated by NO-regulated cGMP-dependent protein kinase and other kinases. However, treatment with thapsigargin led to a significant enhancement of cytosolic as well as mitochondrial Ca 2+ level in APPsw PC12 cells (Fig. 8B and D) . These data suggest that after an ER stress the Ca 2+ homeostasis is easily disturbed in APP-transfected cells.
We also found the highest levels of NOS activity and increased AA release following thapsigargin stimulation in APPsw PC12 cells, suggesting that NOS and AA release are, at least in part, regu- Then, 40 µg of proteins was subjected to 10% polyacrylamide gel SDS/PAGE and analyzed for cPLA 2 expression by immunoblotting using rabbit polyclonal anti-cPLA 2 antibody (diluted 1 : 200) as described in Material and Methods. The photographic inserts show representative Western blot analysis from 6 separate experiments. The results of densitometric analysis are means ± S.E.M. from 6 experiments. **P < 0.01 versus untreated PC12 cells, ## P < 0.01 versus untreated APPwt PC12 cells, && P < 0.01 versus untreated APPsw PC12 cells by two-way ANOVA followed by Newman-Keuls post-hoc test. lated by an increase in [Ca 2+ ] i after thapsigargin-induced release from the ER (Fig. 9) .
Taken together, our observations of enhanced NOS activity and AA release but unchanged cytosolic and mitochondrial [Ca 2+ ] in APP-transfected cells do not support the assumption of a major role of Ca 2+ in modulating the NOS and cPLA 2 activity in these cells (Fig. 8) . 
An elevated oxidative stress due to the NOinduced mitochondrial dysfunction (Keil et al., 2004) could be a possible explanation for the enhanced cPLA 2 activity in the transfected PC12 cells. This option is supported by the previous finding indicating an elevation of cPLA 2 activity following H 2 O 2 stress (Chalimoniuk et al., 2006) . In agreement with these assumptions, cytosolic ROS levels assayed by the DCF method were significantly higher in APPsw and APPwt PC12 cells compared to control PC12 cells (Fig. 10A) . Similarly, mitochondria-derived ROS levels measured with the fluorescent dye DHR were also slightly, but significantly increased in APPsw cells compared to APPwt and control PC12 cells (Fig.  10B) . By contrast, superoxide radicals assayed by the fluorescent dye DHE were significantly decreased in APPwt and APPsw cells compared to control PC12 cells (Fig. 10C) , suggesting an elevated activity of antioxidant enzymes as a partial compensating mechanism (Schüssel et al., 2006) . This was supported by our observations that Cu/Zn-superoxide dismutase and glutathione reductase activities were significantly increased in APPsw cells compared to APPwt and control PC12 cells, whereas glutathione peroxidase activity was significantly decreased in APPsw cells (Fig. 11) .
dISCuSSION
There is a growing body of evidence suggesting that NO plays an important role in the pathomechanism of Alzheimer's disease (AD) within the cascade of events leading from enhanced intracellular Aβ accumulation to enhanced vulnerability to apoptosis and cell death (Luth & Arendt, 1998; Luth et al., 2001; Lahiri et al., 2003) . In PC12 cells transfected with human wild type or mutated APP (APPwt, APPsw), an increased Aβ level is associated with an enhanced NO level, impaired mitochondrial function, and depletion of ATP (Eckert et al., 2001; Marques et al., 2003; Keil et al., 2004) . The higher NO concentration activates AA release by cPLA 2 (Chalimoniuk et al., 2006) . Elevated AA in turn might contribute to neuronal dysfunction and cell death as it has been suggested from the data of enhanced AA release in AD brain (Stephenson et al., 1996) . Our results indicate a direct relationship between Aβ concentration, NOS activity and cPLA 2 level and AA release in cells. This sequence of events has significant consequences in cell degeneration and death. Since usually very high extracellular levels of Aβ are needed to induce oxidative stress and enhance NO levels in neuronal cells, we used two PC12-transfected cell In agreement with this assumption we found elevated NOS activity, increased NO level, and higher intra-as well as extracellular concentration of cGMP in APPwt cells as well as in APPsw versus PC12 control cells. Similarly to our findings using extracellular NO donors like SNP (Chalimoniuk et al., 2006) , the elevated intracellular NO concentration was accompanied by increased cPLA 2 protein level, as well as AA release. Moreover, an increase of phospho-cPLA 2 was observed confirming the important role of protein kinases for cPLA 2 activation (Gijon et al., 2000; Xu et al., 2002; Evans et al., 2002; Chalimoniuk et al., 2006) . The relationship between the elevated Aβ level and the enhanced cPLA 2 activity was confirmed by the always higher effects in the APPsw PC12 cells (higher Aβ level) in comparison to the APPwt PC12 cells (lower Aβ level). Moreover, our findings indicating that the γ-secretase inhibitor DAPT, which reduces Aβ generation (Keil et al., 2004) , also reduced the elevated AA release supported the proposed mechanism.
Although many findings clearly show that cPLA 2 activity is regulated by [Ca 2+ ] i , (Handlogten et al., 2001; Strokin et al.; Shimizu et al., 2004) , several of our findings rule out alterations of [Ca 2+ ] i being of major relevance. Neither cytosolic nor mitochondrial [Ca 2+ ] were different in the three PC12 cell lines which showed substantial differences in AA release under basal conditions. Thus, [Ca 2+ ] i is probably not the most important factor for the link of initial NO generation with AA release, but may contribute to the responses after an ER stress.
On the other hand, cPLA 2 activity is regulated by oxidative stress and by elevated intracellular ROS (Sapirstein et al., 1996; Samanta et al., 1998; Chalimoniuk et al., 2006) . In our studies, increased cytosolic and mitochondrial free radical levels were observed. However, concomitantly a protective pathway(s) was stimulated that led to higher SOD activity and to decreased levels of superoxide radicals (O 2 -) in APPwt-and APPsw-transfected cells. However, all these events were not able to protect cells against higher ROS formation. On the basis of our results we suggest that the higher ROS formation in the APP-transfected cells compared to control PC12 cells may also be involved in the enhancement of cPLA 2 activity.
Decreased O 2 -levels could be caused by increased Cu,Zn-SOD and glutathione reductase activ- Values are means ± S.E.M. from 6 experiments. **P < 0.01, *P < 0.05 versus control PC12 cells by one-way ANOVA followed by Newman-Keuls post-hoc test.
